BELLEVUE GROUP AG – Axsome Therapeutics, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$22.15M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+16.50%
quarter
Axsome Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -39.24% | -320.61K shares | -9.14M | $44.62 | 496.52K |
| Q2 2022 | share | Increase | +13.57% | 97.65K shares | 1.51M | $38.3 | 817.14K |
| Q1 2022 | share | Increase | +10.36% | 67.54K shares | 5.14M | $41.39 | 719.48K |
| Q4 2021 | share | Decrease | -13.42% | -101.00K shares | -187K | $38.02 | 651.93K |
| Q3 2021 | share | Increase | +113.89% | 400.92K shares | 1.07M | $32.96 | 752.94K |
| Q2 2021 | share | Increase | 0.00% | 352.02K shares | 23.74M | $67.46 | 352.02K |